Oncology Clinical Trials in Minneapolis, MN

As of August 2026, 159 paid clinical trials are recruiting for Oncology in Minneapolis, Minnesota. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: August 31, 2026.

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

Newly added in Minneapolis

Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.

Capturing Food Intake in Patients Undergoing Radiation Therapy for Cancer

for Cancer

1 location in Minneapolis

Sponsor: University of Minnesota

Sex: All·Age: 18+

Code: NCT07682714·Recruiting·Listed Jul 6, 2026

Apply to this trial

160 clinical trials for Oncology

·Clear filters·

Email me when a new oncology trial opens in Minneapolis, MN.

A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer

for Pancreatic Cancer

Sites in Minneapolis, Saint Louis Park +47 more locations

Sponsor: Astellas Pharma Global Development, Inc.

Sex: All·Age: 18+

Code: NCT07409272·Phase 3·Recruiting·Listed Feb 2026

Apply to this trial

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

for Advanced Non-Small Cell Lung Cancer

Drug: PF-08634404

Sites in Minneapolis, Edina +204 more locations

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07222566·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.

for Carcinoma, Hepatocellular

Drug: PF-08634404

Sites in Minneapolis, Saint Paul +39 more locations

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07227012·Phase 1, Phase 2·Recruiting·Listed Nov 2025

Apply to this trial

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

for Metastatic Castration-resistant Prostate Cancer

Sites in Minneapolis +42 more locations

Sponsor: Amgen

Sex: Male·Age: 18+

Code: NCT07213674·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

for Breast Neoplasms

Sites in Minneapolis, Saint Louis Park +123 more locations

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT07174336·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

for Melanoma

Sites in Minneapolis, Fridley +89 more locations

Sponsor: Regeneron Pharmaceuticals

Sex: All·Age: 18+

Code: NCT06246916·Phase 3·Recruiting·Listed Feb 2024

Apply to this trial

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

for Breast Cancer

Sites in Minneapolis, Saint Louis Park +170 more locations

Sponsor: Stemline Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06492616·Phase 3·Recruiting·Listed Jul 2024

Apply to this trial

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

for Endometrial Cancer

Sites in Minneapolis, Edina +60 more locations

Sponsor: Genmab

Sex: Female·Age: 18+

Code: NCT07166094·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

for Carcinoma, Non-Small-Cell Lung

Drug: Amivantamab

Sites in Minneapolis, Rochester +123 more locations

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT06667076·Phase 2·Recruiting·Listed Oct 2024

Apply to this trial

A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer

for Colorectal Neoplasms

Sites in Minneapolis, Saint Louis Park +106 more locations

Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Sex: All·Age: 18+

Code: NCT05253651·Phase 3·Recruiting·Listed Feb 2022

Apply to this trial

Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

for Cervical Cancer

Sites in Minneapolis, Edina +126 more locations

Sponsor: Pfizer

Sex: Female·Age: 18+

Code: NCT06952660·Phase 4·Recruiting·Listed May 2025

Apply to this trial

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

for Triple Negative Breast Cancer

Sites in Minneapolis, Saint Louis Park +122 more locations

Sponsor: Gilead Sciences

Sex: All·Age: 18+

Code: NCT05633654·Phase 3·Recruiting·Listed Dec 2022

Apply to this trial

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

for Carcinoma, Non-Small-Cell Lung

Drug: LY3537982

Sites in Minneapolis, Saint Paul +86 more locations

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT06119581·Phase 3·Recruiting·Listed Nov 2023

Apply to this trial

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

for Endometrial Cancer

Sites in Minneapolis +45 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: Female·Age: 18+

Code: NCT06952504·Phase 3·Recruiting·Listed May 2025

Apply to this trial

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

for PIK3CA Mutation

Sites in Minneapolis +51 more locations

Sponsor: Relay Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06982521·Phase 3·Recruiting·Listed May 2025

Apply to this trial

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

for Breast Cancer

Sites in Minneapolis +58 more locations

Sponsor: Hoffmann-La Roche

Sex: All·Age: 18+

Code: NCT06790693·Phase 3·Recruiting·Listed Jan 2025

Apply to this trial

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

for Epithelial Ovarian Cancer

Sites in Minneapolis, Saint Louis Park +65 more locations

Sponsor: AbbVie

Sex: Female·Age: 18+

Code: NCT06890338·Phase 2·Recruiting·Listed Mar 2025

Apply to this trial

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

for Neoplasms

Sites in Minneapolis, Rochester +76 more locations

Sponsor: Celgene

Sex: All·Age: All ages

Code: NCT03435796·Phase 2, Phase 3·Recruiting·Listed Feb 2018

Apply to this trial

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

for Large B-cell Lymphoma

Sites in Minneapolis +60 more locations

Sponsor: Allogene Therapeutics

Sex: All·Age: 18+

Code: NCT06500273·Phase 2·Recruiting·Listed Jul 2024

Apply to this trial

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

for Breast Neoplasms

Sites in Minneapolis, Maple Grove +36 more locations

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 18+

Code: NCT06926868·Phase 2, Phase 3·Recruiting·Listed Apr 2025

Apply to this trial

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

for Non-Small Cell Lung Cancer

Drug: sigvotatug vedotin

Sites in Minneapolis, Saint Louis Park +73 more locations

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT06758401·Phase 3·Recruiting·Listed Jan 2025

Apply to this trial

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

for Carcinoma, Non-Small Cell Lung

Drug: sigvotatug vedotin

Sites in Minneapolis, Saint Paul +102 more locations

Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Sex: All·Age: 18+

Code: NCT04389632·Phase 1·Recruiting·Listed May 2020

Apply to this trial

A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

for Ovarian Cancer

Drug: INCB123667

Sites in Minneapolis +37 more locations

Sponsor: Incyte Corporation

Sex: Female·Age: 18 - 99

Code: NCT07023627·Phase 2·Recruiting·Listed Jun 2025

Apply to this trial

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

for Non Small Cell Lung Cancer

Sites in Minneapolis, Rochester +42 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06312137·Phase 3·Recruiting·Listed Mar 2024

Apply to this trial

FOG-001 in Locally Advanced or Metastatic Solid Tumors

for Cancer

Sites in Minneapolis, Rochester +28 more locations

Sponsor: Parabilis Medicines, Inc.

Sex: All·Age: 18+

Code: NCT05919264·Phase 1, Phase 2·Recruiting·Listed Jun 2023

Apply to this trial

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

for Hormone Receptor Positive HER-2 Negative Breast Cancer

Sites in Minneapolis, Rochester +32 more locations

Sponsor: Puma Biotechnology, Inc.

Sex: All·Age: 18+

Code: NCT06369285·Phase 2·Recruiting·Listed Apr 2024

Apply to this trial

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

for Breast Cancer

Sites in Minneapolis, Edina +100 more locations

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07062965·Phase 3·Recruiting·Listed Jul 2025

Apply to this trial

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

for Prostate Cancer

Drug: JANX007

Sites in Minneapolis, Rochester +31 more locations

Sponsor: Janux Therapeutics

Sex: Male·Age: 18 - 100

Code: NCT05519449·Phase 1·Recruiting·Listed Aug 2022

Apply to this trial

Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)

for Brain Tumor, Recurrent

Sites in Minneapolis +50 more locations

Sponsor: GT Medical Technologies, Inc.

Sex: All·Age: All ages

Code: NCT04427384·Recruiting·Listed Jun 2020

Apply to this trial

A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer

for Neoplasms

Sites in Minneapolis +24 more locations

Sponsor: Eli Lilly and Company

Sex: All·Age: 1 - 39

Code: NCT05999994·Phase 2·Recruiting·Listed Aug 2023

Apply to this trial

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

for Myelofibrosis

Sites in Minneapolis +29 more locations

Sponsor: Sumitomo Pharma America, Inc.

Sex: All·Age: 18+

Code: NCT04176198·Phase 1, Phase 2·Recruiting·Listed Nov 2019

Apply to this trial

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

for Ovarian Cancer

Drug: Bevacizumab

Sites in Minneapolis +31 more locations

Sponsor: Daiichi Sankyo

Sex: Female·Age: 18+

Code: NCT06819007·Phase 3·Recruiting·Listed Feb 2025

Apply to this trial

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

for Breast Cancer

Drug: Palazestrant

Sites in Minneapolis +32 more locations

Sponsor: Olema Pharmaceuticals, Inc.

Sex: All·Age: 18+

Code: NCT07085767·Phase 3·Recruiting·Listed Jul 2025

Apply to this trial

Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

for Metastatic Breast Cancer

Sites in Minneapolis, Rochester +29 more locations

Sponsor: LeonaBio

Sex: All·Age: 18+

Code: NCT05696626·Phase 3·Recruiting·Listed Jan 2023

Apply to this trial

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

for Non-Small Cell Lung Cancer

Drug: Ivonescimab

Sites in Minneapolis, Saint Paul +92 more locations

Sponsor: Summit Therapeutics

Sex: All·Age: 18+

Code: NCT06767514·Phase 3·Recruiting·Listed Jan 2025

Apply to this trial

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

for Acute Myeloid Leukemia

Drug: Venetoclax

Sites in Minneapolis, Rochester +42 more locations

Sponsor: Kura Oncology, Inc.

Sex: All·Age: 18+

Code: NCT05735184·Phase 1·Recruiting·Listed Feb 2023

Apply to this trial

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

for Breast Cancer

Sites in Minneapolis +112 more locations

Sponsor: Agendia

Sex: All·Age: 18+

Code: NCT03053193·Recruiting·Listed Feb 2017

Apply to this trial

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

for Epithelial Ovarian Cancer

Sites in Minneapolis, Rochester +24 more locations

Sponsor: TORL Biotherapeutics, LLC

Sex: Female·Age: 18+

Code: NCT06690775·Phase 2·Recruiting·Listed Nov 2024

Apply to this trial

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

for Multiple Myeloma

Drug: Teclistamab

Sites in Minneapolis, Rochester +33 more locations

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT07518186·Phase 3·Recruiting·Listed Apr 2026

Apply to this trial

A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

for Colorectal Cancer

Sites in Minneapolis, Rochester +20 more locations

Sponsor: AbbVie

Sex: All·Age: 18+

Code: NCT07023289·Phase 2·Recruiting·Listed Jun 2025

Apply to this trial

Top Research Study Locations in Minneapolis

Researchers run research studies in Minneapolis, MN at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.

Site	Specializes in	Active trials
University of Minnesota	Parkinson Disease, Depression, Amyotrophic Lateral Sclerosis	300
Abbott-Northwestern Hospital	Acute Myeloid Leukemia, Stage IV Lung Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8	83
Hennepin County Medical Center	Malignant Solid Neoplasm, Stage IV Renal Cell Cancer AJCC v8, Stage IVB Prostate Cancer AJCC v8	69
University of Minnesota/Masonic Cancer Center	Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia, Malignant Solid Neoplasm	36
Minneapolis Heart Institute Foundation	Coronary Artery Disease, Cardiovascular Diseases, Heart Failure	31
Minneapolis VA Health Care System, Minneapolis, MN	Amputation, Bipolar Disorder, Spinal Cord Diseases	29
Children's Hospitals and Clinics of Minnesota - Minneapolis	Malignant Solid Neoplasm, Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia	25
Health Partners Inc	Stage IVB Prostate Cancer AJCC v8, Ovarian Carcinoma, Acral Lentiginous Melanoma	20
University of Minnesota Medical Center	ADA SCID, Advanced Melanoma, Aortic Stenosis	17
Masonic Cancer Center	Acute Myeloid Leukemia, Smoking Cessation, Acute Lymphoblastic Leukemia	15
Minneapolis Heart Institute	Coronary Artery Disease, Cardiovascular Diseases, Heart Diseases	15
Minneapolis VA Medical Center	Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8	14
Abbott Northwestern Hospital	AMI, Acute Stroke, Aneurysm Cerebral	10
M Health Fairview University of Minnesota Medical Center	Ischemic Stroke, Adamantinomatous Craniopharyngioma, Atrial Fibrillation	8
Minneapolis VA Health Care System	Heart Failure, Aging Related Cognitive Decline, Chronic Obstructive Pulmonary Disease	8
University of Minnesota Masonic Children's Hospital	Fabry Disease, High-Risk Neuroblastoma, Hypochondroplasia	8
University of Minnesota Medical School	Niemann-Pick Type C Disease, Advanced Solid Tumor, Alopecia	8
Children's Hospitals and Clinics of Minnesota	Cystic Fibrosis, B-cell Acute Lymphoblastic Leukemia, Caregiver Burden	8
Allina Health Cancer Institute - Abbott Northwestern Hospital	Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Advanced Hepatocellular Carcinoma	7
Children's Minnesota	Ciliary Body Medulloepithelioma, Craniopharyngioma, Craniopharyngioma, Child	7
Masonic Cancer Center at University of Minnesota	Myelodysplastic Syndromes, Acute Leukemia, Acute Myeloid Leukemia	7
Masonic Cancer Center, University of Minnesota	Adenocarcinoma of Lung, Alcohol-Related Carcinoma, Epithelial Ovarian Cancer	7
Children's Hospital and Clinics of Minnesota	Neuroblastoma, ALL, AML	6
Hennepin Healthcare	Acute Respiratory Failure, Awareness, Carcinoma, Hepatocellular	6
International Diabetes Center	Obesity, Type 1 Diabetes Mellitus, Type 2 Diabetes	6

Active & Upcoming Studies in Minneapolis (2026)

Recruiting trials in Minneapolis grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.

Vaccines (2 active studies)

Common conditions studied in Minneapolis

Heart Failure (17 active studies)
Acute Myeloid Leukemia (16 active studies)
Ovarian Cancer (13 active studies)
Breast Cancer (12 active studies)
Coronary Artery Disease (11 active studies)
Endometrial Cancer (11 active studies)

Leading research sponsors in Minneapolis

University of Minnesota
National Cancer Institute (NCI)
Masonic Cancer Center, University of Minnesota
VA Office of Research and Development
Children's Oncology Group

Frequently asked questions

How many paid clinical trials are currently recruiting in Minneapolis?

There are approximately 907 recruiting clinical trials in Minneapolis, Minnesota listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.

Do clinical trials in Minneapolis pay participants?

Most recruiting trials in Minneapolis compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.

Who can participate in a clinical trial in Minneapolis?

Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.

What conditions are most commonly studied in Minneapolis?

The most common conditions under active study in Minneapolis include Heart Failure (17), Acute Myeloid Leukemia (16), Ovarian Cancer (13), Breast Cancer (12), among many others. Browse the list above to explore every recruiting trial.

Are there clinical trials for healthy volunteers in Minneapolis?

Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Minneapolis on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.

How do I enroll in a clinical trial in Minneapolis?

Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.

Where can I take part in paid clinical trials in Minneapolis?

Recruiting research sites in Minneapolis include University of Minnesota, Abbott-Northwestern Hospital, Hennepin County Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.

What kinds of studies are recruiting in Minneapolis right now?

The largest active categories in Minneapolis are Cancer & tumors (244), Cardiovascular (72), Neurology & pain (54). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.

Browse more clinical trials

Other cities in Minnesota

Rochester, MN(1,209)Saint Paul, MN(176)Saint Louis Park, MN(122)Edina, MN(117)Coon Rapids, MN(110)Duluth, MN(103)Maplewood, MN(87)Deer River, MN(69)Virginia, MN(69)Woodbury, MN(69)Burnsville, MN(68)Hibbing, MN(68)Sandstone, MN(67)Maple Grove, MN(66)Bemidji, MN(60)Saint Cloud, MN(57)Brainerd, MN(56)Shakopee, MN(50)Robbinsdale, MN(49)Waconia, MN(49)Stillwater, MN(47)Monticello, MN(40)Willmar, MN(40)New Ulm, MN(37)Princeton, MN(34)Mankato, MN(33)Wyoming, MN(33)Detroit Lakes, MN(29)Chaska, MN(27)Fosston, MN(25)Park Rapids, MN(24)Worthington, MN(21)Ely, MN(20)International Falls, MN(20)Moose Lake, MN(20)Aitkin, MN(19)Baxter, MN(19)Thief River Falls, MN(19)Cambridge, MN(18)Crosslake, MN(16)Pequot Lakes, MN(16)Pine River, MN(16)Staples, MN(16)Albert Lea, MN(15)Bloomington, MN(9)Marshall, MN(9)New Brighton, MN(8)Alexandria, MN(7)Fridley, MN(7)Minneota, MN(6)Plymouth, MN(6)Golden Valley, MN(5)Minnetonka, MN(5)Richfield, MN(5)Roseville, MN(4)Sartell, MN(4)Dilworth, MN(3)Eagan, MN(3)Eden Prairie, MN(3)Medina, MN(3)

Related healthcare resources in Minnesota

Latest Minneapolis, MN clinical trials research report

Trials by condition in Minneapolis

Heart Failure· 17 Acute Myeloid Leukemia· 16 Ovarian Cancer· 13 Breast Cancer· 12 Endometrial Cancer· 11 Parkinson Disease· 11 Obesity· 10

Conditions in Oncology (Minneapolis, MN)

Solid tumor· 24 Non-small cell lung cancer (NSCLC)· 20 Acute myeloid leukemia (AML)· 18 Breast cancer· 17 Ovarian cancer· 17 Cancer (any)· 13 Colorectal cancer· 11 Endometrial cancer· 11 Hematologic malignancy· 9 Metastatic breast cancer· 8 Multiple myeloma· 8 Myelodysplastic syndromes (MDS)· 8 Melanoma· 8 Leukemia (other)· 7 Non-Hodgkin lymphoma· 7 Neuroblastoma· 7 Prostate cancer· 6 Metastatic prostate cancer· 6 Acute lymphoblastic leukemia· 6 Head and neck cancer· 6 Chronic lymphocytic leukemia (CLL)· 5 Lung cancer· 4 Pancreatic cancer· 4 Cervical cancer· 4 Fallopian tube cancer· 4 Myelofibrosis· 4 Hodgkin lymphoma· 4 Small lymphocytic lymphoma· 4 Triple-negative breast cancer· 3 HER2-negative breast cancer· 3 Esophageal cancer· 3 Kidney cancer· 3 Follicular lymphoma· 3 HER2-positive breast cancer· 2 Gastroesophageal junction cancer· 2 Liver cancer· 2 Bladder cancer· 2 Glioblastoma· 2 Brain cancer· 2 Myeloproliferative neoplasm· 2 Diffuse large B-cell lymphoma (DLBCL)· 2 Marginal zone lymphoma· 2 Burkitt lymphoma· 2 Thyroid cancer· 2 Sarcoma· 2 Gastric cancer· 1 Brain metastases· 1 Mantle cell lymphoma· 1 Osteosarcoma· 1 Ewing sarcoma· 1 Rhabdomyosarcoma· 1 Pediatric cancer· 1 Mesothelioma· 1

Oncology Clinical Trials in Minneapolis, MN

Newly added in Minneapolis

160 clinical trials for Oncology

Top Research Study Locations in Minneapolis

Active & Upcoming Studies in Minneapolis (2026)

Cancer & tumors (244 active studies)

Cardiovascular (72 active studies)

Neurology & pain (54 active studies)

Diabetes & metabolic (44 active studies)

Mental health & behavior (31 active studies)

Pediatric (14 active studies)

HIV / STI (7 active studies)

Eye & vision (5 active studies)

Vaccines (2 active studies)

Common conditions studied in Minneapolis

Leading research sponsors in Minneapolis

Frequently asked questions

How many paid clinical trials are currently recruiting in Minneapolis?

Do clinical trials in Minneapolis pay participants?

Who can participate in a clinical trial in Minneapolis?

What conditions are most commonly studied in Minneapolis?

Are there clinical trials for healthy volunteers in Minneapolis?

How do I enroll in a clinical trial in Minneapolis?

Where can I take part in paid clinical trials in Minneapolis?

What kinds of studies are recruiting in Minneapolis right now?

Browse more clinical trials

Other cities in Minnesota

Related healthcare resources in Minnesota

Trials by condition in Minneapolis

Conditions in Oncology (Minneapolis, MN)